-
-
-
-
-
-
-
FibroBiologics presents thymic organoid data at aging conference
-
-
-
-
-
-
-
FibroBiologics faces additional Nasdaq delisting risk over market value
-
-
-
-
-
-
-
FibroBiologics reports positive preclinical results for disc therapy
-
-
-
-
-
-
-
FibroBiologics reports positive psoriasis treatment study results
-
-
-
-
-
-
-
FibroBiologics (FBLG) opens new Houston lab space
-
-
-
-
-
-
-
FibroBiologics (FBLG) Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics
-
-
-
-
-
-
-
FibroBiologics (FBLG) Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
-
443,905 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

